Program Location:
Hyatt Regency Bethesda
One Bethesda Metro Center (7400 Wisconsin Ave)
Bethesda, MD
Program Overview:
The NCCN Patient Safety Summit has been designed to summarize and disseminate relevant research findings and evidence-based information so participants may affect change in the realm of oncology patient safety within their own organizations. The NCCN 2010 Patient Safety Summit will provide an opportunity for clinical, administrative, regulatory, and industry professionals to discuss best practices in oncology patient safety as well as to disseminate advances in oncology patient safety systems and processes.
Patient safety has long been recognized as an integral component of quality medical care. In the past decade, the spotlight on safety in medicine has only become brighter, with the publication of countless reports from the Institute of Medicine, the Institute for Healthcare Improvement, and the National Patient Safety Foundation, among others. The stakes are especially high in oncology, and avoiding error is imperative in delivering radiation therapy, chemotherapy, and other high-risk treatments. More specifically, earlier this year The New York Times ran a series of articles about treatment errors that have occurred in radiation therapy, which has further intensified discussions about the need to improve safety for cancer patients.
The growing attention to oncology patient safety and medical error by the media and others requires a timely and well-considered plan of action from the oncology community and its stakeholders.
Program Goals:
Educational Objectives:
Intended Audience:
This educational program is designed to meet the educational needs of oncology physicians and nurses who manage patients with cancer, quality assurance administrators, administrative directors, nursing directors, clinical pharmacists, pharmacy directors, risk managers, as well as pharmaceutical industry representatives and equipment manufacturers.
Agenda:
7:30 – 8:00 AM | Breakfast |
8:00 – 8:15 AM | Welcome |
8:15 – 9:00 AM | Keynote Address |
9:00 - 10:30 AM | Panel Discussion: Radiation Safety – Putting Prevention into Daily Practice |
10:30 - 10:45 AM | Break |
10:45 AM - 12:15 PM | Strategies to Prevent Oral Chemotherapy Errors |
12:15 - 12:30 PM | Break |
12:30 - 1:45 PM | Lunch Presentation: Safety and Accountability |
1:45 - 3:15 PM | Panel Discussion: Improving the Quality of Cancer Care through the Prevention of Health Care-Associated Infections |
3:15 - 3:30 PM | Closing Remarks |
Accreditation:
Physicians
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.
NCCN designates this educational activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NursesThis activity is approved for 5.75 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.
Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.
Pharmacists
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
The Postgraduate Institute for Medicine designates this continuing education activity for 4.5 contact hour(s) (0.45 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number 0809-9999-10-158-L01-P)
One Universal Activity Number is provided for this activity. It is the responsibility of the pharmacist to claim credit only for the sessions attended.
Fee Information
A registration fee will apply. Please see Registration Information for fees. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 4-6 weeks.
In order to receive a statement of credit, participants will need to attend the educational activity and complete the evaluation form. Partial credit will be awarded. Statements of credit will be mailed within 4 to 6 weeks of the meeting. Pharmacists should note that they must attend a minimum of one hour to be eligible for credit. Please refer to the registration section for information regarding fees and refund policy.
This is a knowledge-based educational activity.
Credit hours are subject to change as topics are finalized.
Accommodations:
NCCN does not have a block of rooms reserved for attendees at the Hyatt Regency Bethesda; however, there are rooms available at the hotel. Please book your reservation online or by calling (301) 657-1234.
Supporters:
This Summit is supported by an educational grant from Pfizer.
This Summit is supported by GE Healthcare.
This Summit is supported by Varian Medical Systems.
This summit is supported by Amgen in collaboration with Stand Up To Cancer.
Registration Information:
Health Care Professional from NCCN Member Institution - $95.00
Health Care Professional from Non-NCCN Member Institution - $195.00
Government Employee - $95.00
Industry - $395.00
NCCN Corporate Council Member - $295.00
Sponsorship and Advertising Opportunities:
Organizations who are interested in sponsoring this program or advertising within the sponsorship guide are encouraged to click here for more information or contact Jennifer Tredwell, Senior Manager Marketing & Communications.
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved